Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells

被引:2
|
作者
Yalcintepe, Leman [1 ]
Erdag, Demet [1 ]
Akbas, Fahri [2 ]
Kucukkaya, Bahire [3 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Biophys, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey
[3] Istanbul Yeni Yuzyil Univ, Fac Med, Dept Biophys, Istanbul, Turkey
关键词
doxorubicin; drug resistance; intracellular calcium; iron; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MULTIDRUG-RESISTANCE; INTRACELLULAR CALCIUM; MOLECULAR-MECHANISMS; NA+/CA2+ EXCHANGERS; THERAPY RESISTANCE; P-GLYCOPROTEIN; CANCER; SENSITIVITY; METABOLISM;
D O I
10.1111/1440-1681.13295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Iron is an essential trace element especially in cell proliferation, and growth for various cellular events. An increasing amount of research has shown that iron metabolism is altered in tumour cells which usually have rapid growth rates. However, the number of studies on iron metabolism, and calcium regulation are limited in drug-resistant tumour cells. Previously, we have shown that modulation of iron metabolism through iron chelation regulated the intracellular calcium, and increased the doxorubicin sensitivity. In the present study, we investigated the effects of iron on mRNA expression profiles of fifteen key genes (IP(3)R1/2/3, RYR1/2, SERCA1/2/3, NCX1/2/3, PMCA1/2/3, and PMCA4) related to calcium homeostasis in the parental cell line K562 and its subclone doxorubicin-resistant K562 cells. According to the Delta Delta Ct method with a two-fold expression difference (P < .05) as a cut-off level, although iron showed differential effects on most of the genes, IP3R and PMCA genes were especially determined to have changed significantly. These results show that iron metabolism is an important metabolism due to changes in the expression of genes involved in calcium regulation and is a new perspective to overcome cancer/drug resistance.
引用
收藏
页码:1221 / 1230
页数:10
相关论文
共 50 条
  • [31] Interference of aluminium on iron metabolism in erythroleukaemia K562 cells
    Pérez, G
    Garbossa, G
    Sassetti, B
    Di Risio, C
    Nesse, A
    JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 76 (02) : 105 - 112
  • [32] Dynamics of the cytosolic chelatable iron pool of K562 cells
    Breuer, W
    Epsztejn, S
    Cabantchik, ZI
    FEBS LETTERS, 1996, 382 (03) : 304 - 308
  • [33] miR-218 Inhibits Erythroid Differentiation and Alters Iron Metabolism by Targeting ALAS2 in K562 Cells
    Li, Yanming
    Liu, Shuge
    Sun, Hongying
    Yang, Yadong
    Qi, Heyuan
    Ding, Nan
    Zheng, Jiawen
    Dong, Xunong
    Qu, Hongzhu
    Zhang, Zhaojun
    Fang, Xiangdong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (12): : 28156 - 28168
  • [34] CJZ3, a lomerizine derivative, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
    Ji, Bian-Sheng
    He, Ling
    Liu, Guo-Qing
    DRUG DEVELOPMENT RESEARCH, 2006, 67 (11) : 862 - 869
  • [35] EFFECT OF PROCHLORPERAZINE ON DOXORUBICIN CONTENT AND CYTO-TOXICITY IN K562 CELLS
    RICHMAN, SP
    LALLEY, K
    KIEFER, S
    WOODCOCK, TM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 338 - 338
  • [36] Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole
    Ishikawa, M
    Fujita, R
    Takayanagi, M
    Takayanagi, Y
    Sasaki, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (01) : 112 - 115
  • [37] Liposome-based intracellular kinetics of doxorubicin in K562/DOX cells
    Xu, Dong-Hang
    Gao, Jian-Qing
    Liang, Wen-Quan
    PHARMAZIE, 2008, 63 (09): : 646 - 649
  • [38] Circumvention of acquired resistance to doxorubicin in K562 human leukemia cells by oxatomide
    Ishikawa, M
    Fujita, R
    Furusawa, S
    Takayanagi, M
    Sasaki, K
    Satoh, S
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (10) : 1185 - 1187
  • [39] THE EFFECT OF IMATINIB MESYLATE ON THE SIGNAL TRANSDUCTION CASCADE REGULATING TELOMERASE ACTIVITY IN K562 CELLS AND IN K562 CELLS RESISTANT TO IMATINIB MESYLATE
    Mor, R.
    Uziel, O.
    Shpilberg, O.
    Lahav, J.
    Raanani, P.
    Rabizadeh, E.
    Zimra, Y.
    Lahav, M.
    Granot, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 43 - 43
  • [40] Expression profile of Notch-related genes in multidrug resistant K562/A02 cells compared with parental K562 cells
    Yan, S.
    Ma, D.
    Ji, M.
    Guo, D.
    Dai, J.
    Zhao, P.
    Ji, C.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (02) : 150 - 158